Crossmark

Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)

Crossref DOI link: https://doi.org/10.1016/j.aohep.2025.101789

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Younossi, Zobair M. https://orcid.org/0000-0001-9313-577X
Paik, James M.

Henry, Linda

Pollock, Richard F.

Stepanova, Maria

Nader, Fatema
Funding

Funding for this research was provided by:

Siemens Healthineers USA
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-02-05
More Information

This article is maintained by: Elsevier

Article Title: Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)

Journal Title: Annals of Hepatology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.aohep.2025.101789

Content Type: article

Copyright: © 2025 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below